Question

I am a breastfeeding mother and i want to know if it is safe to use N(4)-(2,6-Dimethoxy-4-methyl-5-((3-trifluoromethyl)phenoxy)-8-quinolinyl)-1,4-pentanediamine? Is N(4)-(2,6-Dimethoxy-4-methyl-5-((3-trifluoromethyl)phenoxy)-8-quinolinyl)-1,4-pentanediamine safe for nursing mother and child? Does N(4)-(2,6-Dimethoxy-4-methyl-5-((3-trifluoromethyl)phenoxy)-8-quinolinyl)-1,4-pentanediamine extracts into breast milk? Does N(4)-(2,6-Dimethoxy-4-methyl-5-((3-trifluoromethyl)phenoxy)-8-quinolinyl)-1,4-pentanediamine has any long term or short term side effects on infants? Can N(4)-(2,6-Dimethoxy-4-methyl-5-((3-trifluoromethyl)phenoxy)-8-quinolinyl)-1,4-pentanediamine influence milk supply or can N(4)-(2,6-Dimethoxy-4-methyl-5-((3-trifluoromethyl)phenoxy)-8-quinolinyl)-1,4-pentanediamine decrease milk supply in lactating mothers?

Answer by DrLact: About N(4)-(2,6-Dimethoxy-4-methyl-5-((3-trifluoromethyl)phenoxy)-8-quinolinyl)-1,4-pentanediamine usage in lactation

No information is available on the use of N(4)-(2,6-Dimethoxy-4-methyl-5-((3-trifluoromethyl)phenoxy)-8-quinolinyl)-1,4-pentanediamine during breastfeeding. N(4)-(2,6-Dimethoxy-4-methyl-5-((3-trifluoromethyl)phenoxy)-8-quinolinyl)-1,4-pentanediamine can cause hemolysis in patients with glucose-6-phosphate dehydrogenase (G6PD) deficiency. If N(4)-(2,6-Dimethoxy-4-methyl-5-((3-trifluoromethyl)phenoxy)-8-quinolinyl)-1,4-pentanediamine is required, testing the mother and infant for G6PD deficiency is required before the drug is given to a nursing mother. Because the half-life of N(4)-(2,6-Dimethoxy-4-methyl-5-((3-trifluoromethyl)phenoxy)-8-quinolinyl)-1,4-pentanediamine averages 15 days, the manufacturer recommends that breastfeeding should not breastfeed for 3 months after the dose if the infant is G6PD deficient.

Alternate Drugs

Tenofovir(Safe)
Amikacin(Safe)
Neomycin(Safe)
Valganciclovir(Low Risk)
Amantadine(Low Risk)
Demeclocycline(Low Risk)
Nafcillin(Safe)
Ganciclovir(Low Risk)
Cefixime(Safe)
Econazole(Safe)
Moxifloxacin(Low Risk)
Primaquine(Low Risk)
Cefepime(Safe)
Efavirenz(Unsafe)
Lindane(Unsafe)
Malathion(Low Risk)
Didanosine(Unsafe)
Saquinavir(Unsafe)
Methicillin(Low Risk)
Cefdinir(Safe)
Meropenem(Safe)
Cefazolin(Safe)
Ritonavir(Unsafe)
Lomefloxacin(Low Risk)
Atovaquone(Low Risk)
Famciclovir(Low Risk)
Cefaclor(Safe)
Abacavir(Safe)
Nevirapine(Low Risk)
Levofloxacin(Low Risk)
Linezolid(Low Risk)
Erythromycin(Low Risk)
Nelfinavir(Unsafe)
Kanamycin(Safe)
Clindamycin(Low Risk)
Naftifine(Safe)
Cefprozil(Safe)
Aztreonam(Safe)
Capreomycin(Low Risk)
Dapsone(Low Risk)
Acyclovir(Safe)
Rifaximin(Safe)
Gatifloxacin(Low Risk)
Ertapenem(Safe)
Cefoxitin(Safe)
Indinavir(Unsafe)
Enoxacin(Low Risk)
Zidovudine(Low Risk)
Ofloxacin(Safe)
Cefotetan(Safe)
Doxycycline(Low Risk)
Quinine(Safe)
Primaquine(Low Risk)
Atovaquone(Low Risk)
Quinine(Safe)
Primaquine(Low Risk)
Pyrantel(Safe)
Lindane(Unsafe)
Malathion(Low Risk)
Atovaquone(Low Risk)
Quinine(Safe)
Atovaquone(Low Risk)
Quinine(Safe)
Primaquine(Low Risk)

Synonyms of N(4)-(2,6-Dimethoxy-4-methyl-5-((3-trifluoromethyl)phenoxy)-8-quinolinyl)-1,4-pentanediamine

Disclaimer: Information presented in this database is not meant as a substitute for professional judgment. You should consult your healthcare provider for breastfeeding advice related to your particular situation. We do not warrant or assume any liability or responsibility for the accuracy or completeness of the information on this Site.